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Background.Weidentiﬁedcathelicidinrelatedantimicrobialprotein(CRAMP)secretedfromtelomeredysfunctionalbonemarrow
cells of late generation telomerase knockout mice (G4mTerc
−/−), increased in blood and various tissues. It can represented human
aging and disease. The main aim of this study is to investigate the sensitive direct enzyme-linked immunosorbent assay (ELISA)
method to analyze the human aging and disease in plasma and the detailed methods to quantify the direct ELISA of these aging
biomarkers.Methods.Telomerelengthsof50healthypersonsaremeasuredwithreal-timePCRinbloodcells.Plasmasamplesfrom
all subjects are analyzed using direct ELISA. Results. From 25 years old person to 78 years, the telomere length becomes shorter
duringaging.Inbloodplasma,theexpressionlevelsofCRAMPincreasesduringhumanaging.Thereisthereversecorrespondence
between the telomere length and the plasma CRAMP level. We also ﬁnd that the fresh plasma, the frozen plasma which thawed less
than 3 times, and the plasma kept in the room temperature less than 3 hours are better for the ELISA analyze of CRAMP in the
plasma. Conclusion. This CRAMP ELISA could become a powerful tool for investigating the relationship between human aging
and telomere length shortening.
1.Introduction
Telomeres cap the chromosome ends and prevent the
activation of DNA damage checkpoints inducing cell cycle
arrest (senescence) or apoptosis [1, 2]. Lots of research
reported that telomere shortening occurred during human
aging and chronic diseases [3]. In addition, mutations in the
enzyme telomerase lead to telomere shortening, impaired
tissue maintenance, and a shortened lifespan in humans
[4–7]a n dm i c e[ 8–11]. These genetic experiments and
diseases showed that telomere shortening could impair with
organmaintenanceandshortenlifespan.However,theactual
contribution of dysfunctional telomeres to natural human
aging and diseases remains under debate. Accumulation of
senescent cells has been detected in skin of aging humans
[12] and primates [13] but not in other organs such as
muscle [14]o rl i v e r[ 15]. In aging telomerase knockout mice
(G4mTerc−/−), telomere dysfunction is associated with a
decline in stem cell function, impaired organ maintenance,
and a shortened lifespan [8–11]. Yet, G4mTerc−/− mice do
not show an accumulation of senescent cells [11]. There
is emerging evidence that senescent cells can be cleared in
vivo by induction of apoptosis [11] and immune responses
[16].
We identiﬁed CRAMP secreted from telomere-
dysfunctional bone-marrow cells of late-generation
telomerase knockout mice (G4mTerc−/−), increased in
blood and in various tissues of aging G4mTerc−/− mice
and represented human aging and disease [17]. The results
indicate that the telomere length shortened with aging and
depend on the other aging markers which connect with
each other. Therefore, the impact of telomere dysfunction
on aging might be underestimated by experiments trying to
detect senescent cells.2 Journal of Biomedicine and Biotechnology
In vitro studies on human cells indicate that low levels of
telomere dysfunction precede cellular senescence in culture
[18]. The identiﬁcation of marker proteins indicating low
levels of telomere dysfunction in presenescent cells could
help to determine the inﬂuence of telomere dysfunction and
DNA damage on human aging and disease. So the clinicians
aregraduallyinterestedintheidentiﬁcationofmarkers,since
thereisgrowingpopulationofhumanssuﬀeringfromdisease
associated with aging.
The main aim of this study is to investigate the sensitive
directenzyme-linkedimmunosorbentassay(ELISA)method
to analyze the human aging and disease in plasma and the
detailed methods to quantify the direct ELISA of these aging
biomarkers.
2. Experimental
2.1. Human Samples. The studies on human samples were
conducted after the declaration of Helsinki. All samples were
used anonymously. All normal human samples have given
written consent to provide blood samples.
2.2. Telomere Length Measurement (qPCR Protocol). We used
a quantitative PCR method to determine telomere length
in whole tissue lysates derived from liver biopsies. First, we
conﬁrmedtelomerelengthmeasurementbyqPCRcorrelated
with the results obtained by Southern blotting—a gold
standard in measuring telomere length. Taq SYBR Green
supermix with ROX (Bio-RAD) was used as master mix. The
total reaction volume was 25 μl containing 25ng of genomic
DNA Measurements were performed on the ABI 7300 Real-
TimePCRsystem(AppliedBiosystems,FosterCity,CA).Asa
standard,areferenceDNAsample(BJ26.5cells)wasincluded
for each measurement to control the day-to-day variations.
Individual DNA samples were measured in triplicates.
The composition of T and S PCR reaction mixes
were identical except for the oligonucleotide primers. The
ﬁnal telomere primer concentrations were as follows: for
telomere ampliﬁcation (T): tel1, 100nM; tel2, 900nM. For
ampliﬁcation of the single-copy gene (S) (human β-globin):
hbg1, 300nM; hbg2, 700nM. The primer sequences (written
5  to 3 )w e r e
tel 1b, CGGTTTGTTTGGGTTTGGGTTTGGGTT-
TGGGTTTGGGTT
tel 2b, GGCTTGCCTTACCCTTACCCTTACCCT-
TACCCTTACCCT
hbg1, GCTTCTGACACAACTGTGTTCACTAGC
hbg2, CACCAACTTCATCCACGTTCACC
The thermal cycling proﬁle for both amplicons began
with 95◦C incubation for 10minutes. For telomere PCR,
there followed 30cycles of 95◦C for 15seconds, 56◦Cf o r
1minute. For hbg PCR, there followed 35 cycles of 95◦Cf o r
15seconds, 54◦Cf o r1m i n u t e .
The relative T/S ratios were converted to telomere length
in base pairs using the correlation curve of the relative T/S
ratio determined by qPCR with TRF length determined
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Figure 1: Telomere length of healthy people. Telomere lengths of
these healthy persons are measured with real-time PCR in blood
cells. From 25-year old person to 78 years, the telomere length
becomes shorter during aging.
by Southern blot analysis of the above-described set of 11
standard cell lines.
2.3. Direct Enzyme-Linked Immunosorbent Assay (ELISA).
Microwellplates(NUNC)werecoatedwith100 μLofplasma
(2-time dilution) and standard proteins: CRAMP 100ng,
50ng, 25ng, 12.5ng, 6.25ng, 3.125ng, 1.6ng, and 0ng at
4◦C overnight. The coated plates were washed three times
with PBS-Tween wash solution and then incubated with
the ﬁrst antibody (CRAMP (Cell Signaling) 1:100) either
overnight at 4◦C or for 2h at room temperature (RT). After
washing the plates three times with PBS-Tween, the assay
was performed by using 100 μl of HRP-hapten conjugate
secondary antibody incubated at RT for 1h. After ﬁve washes
with PBS-Tween, 100 μl of tetramethyl benzidine peroxide-
based substrate solution was added to each well, and 30min
later, 50 μlo f2MH 2SO4 was added to each well to stop the
reaction. The absorbances were read in the microplate reader
in dual-wavelength mode (450–540nm).
2.4. Statistical Analysis. SPSS 16.0 and GraphPad Prism were
used for statistical analyses. The one-sample Kolmogorov-
Smirnov test was used to test for normal distribution of
the data. Data are expressed as the mean ± SD or median
(interquartile range) as appropriate. The unpaired Student’s
t-testwasusedtogenerateP valuesforallofthedatasets.The
error bars represent SD in all ﬁgures.
3. Result
3.1. Telomere Length of Healthy People. Healthy samples
comefrom50healthypersons(25femalesand25males),and
their median age is 46.5, standard deviation is 15.5. Telomere
lengths of these healthy persons are measured with real-time
PCR in blood cells. From 25years old person to 78years, the
telomere length becomes shorter during aging (Figure 1).
3.2.EvaluationofCRAMPinHealthyPeople. Plasmasamples
from all subjects are analyzed using direct ELISA, and
the data are normalized using internal standards. In bloodJournal of Biomedicine and Biotechnology 3
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Figure2:EvaluationofCRAMPinhealthypeople.Inbloodplasma,
the expression levels of CRAMP increases during human aging.
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Figure 3: The relationship between telomere length and CRAMP
level. There is the reverse correspondence between the telomere
length and the plasma CRAMP level.
plasma, the expression levels of CRAMP increases during
human aging (Figure 2).
3.3. The Relationship between Telomere Length and CRAMP
Level. We identiﬁed CRAMP secreted from telomere-
dysfunctional bone-marrow cells of late-generation telom-
erase knockout mice (G4mTerc−/−), increased in blood and
in various tissues of aging G4mTerc−/− mice and represented
human aging and disease (PNAS). In this study we also ﬁnd
the reverse correspondence between the telomere length and
the plasma CRAMP level (Figure 3).
3.4.StandardizationofELISAforCRAMP. Wegettheplasma
from10healthypersons,eachonesacriﬁcedbloodat6times.
That lead us set up the study for the plasma ELISA analyzing
at fresh plasma, stand in the room temperature for 1hour,
2 hours, 3 hours, 4 hours, 5 hours, and we also freeze down
the plasma at −80◦C, then we thaw the samples for 1time,
2times,3times,4times,5times,andwealsohaveonesample
keep in 4◦C overnight.
In all these samples we test the speciﬁcity and sensitivity
ofCRAMPELISA.Theresultsshowthatthefreshplasmahas
thehighestELISAdata,andtheplasmakeepin4◦Covernight
or in the room temperature less than 3 hours, thawed less
than 3 times have little lower data, but the statistics does not
show the signiﬁcant diﬀerence. But the plasma keep in the
room temperature more than 4 hours, thawed more than 4
times have the higher data; the statistics shows the signiﬁcant
diﬀerence (Figure 4(a)).
The results also show that the fresh plasma has the
highestELISAdata,andtheplasmahasbeenkeptin4◦Co v er
1 night, 2, 3, 4, 5 nights or in the room temperature for 1day,
2, 3, 4, 5days have much lower data, and the statistics show
the signiﬁcant diﬀerence (Figure 4(b)).
4. Discussion
Aging is one of the major risk factors for human health
and disease. Accumulating evidences suggested that telomere
length in tissue cells is a marker for biological aging [1, 2].
In this study, telomere lengths of these healthy persons
are measured with-real time PCR in blood cells. From 25-
year old person to 78-year old ﬁfty healthy individuals, the
telomere length becomes shorter during aging, as the usual
reports [7–9]. And the aging rate we could calculate in
this study is 19Bp telomere shorts each year, also as the
usual reports [10–12]. That is why the telomere length is
considered as the aging marker.
We identiﬁed CRAMP secreted from telomere-dys-
functional bone-marrow cells of late-generation telomerase
knockout mice (G4mTerc−/−), increased in blood and in
various tissues of aging G4mTerc−/− mice and represented
human aging and disease [17]. In this study, we get 50
healthy persons whose ages are from 25 to 78 years old, to
analyzetheCRAMPlevelsinhumanplasma.Weﬁndthatthe
young persons have lower CRAMP levels and the old persons
have signiﬁcant higher CRAMP secretion in plasma. We also
could ﬁnd the CRAMP secreting higher with the human
aging, and the SPSS statistics show the signiﬁcant results.
CRAMP secretes higher when the telomere length shortens.
This means that CRAMP level could show the human aging,
and there must be some detail correlation between telomere
shortening and CRAMP secreting, and they both contribute
to the human aging. That needs a lot of detailed studies.
When we analyze the CRAMP ELISA, we always get
plasma samples from clinical department. These samples
may be stored for long time, may be used many times. And
we want to know the exact CRAMP level from these samples,
make the results special and sensitive. Except the ELISA
protocol, there must be some other factors that inﬂuence
the results. The diﬀerent time point samples ELISA results
show that the fresh plasma has the highest ELISA data,
and the plasma keep in 4◦C overnight, or in the room
temperature less than 3hours, thawed less than 3times
have little lower data, but the statistics does not show the
signiﬁcant diﬀerence. But the plasma keep in the room
temperature more than 4hours, thawed more than 4times
have the higher data, the statistics shows the signiﬁcant
diﬀerence. And the plasma keep in 4◦C over 1night, 2, 3, 4,
5n i g h t so ri nt h er o o mt e m p e r a t u r ef o r1d a y ,2 ,3 ,4 ,5d a y s
have much lower data, and the statistics show the signiﬁcant
diﬀerence. This means that when we analyze the CRAMP
levels, we must make sure that the plasma samples are fresh,4 Journal of Biomedicine and Biotechnology
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Figure 4: Standardization of ELISA for CRAMP. (a) The results show that the fresh plasma has the highest ELISA data, and the plasma kept
in4◦Covernightorintheroomtemperaturelessthan3hours,andtheplasmathawedlessthan3timeshavelittlelowerdata,butthestatistics
does not show the signiﬁcant diﬀerence. But the plasma kept in the room temperature more than 4hours, thawed more than 4times have
the higher data, the statistics shows the signiﬁcant diﬀerence. (b) The results show that the fresh plasma has the highest ELISA data, and the
plasma kept in 4◦C over 1night, 2, 3, 4, 5 nights or in the room temperature for 1day 2, 3, 4, 5 days have much lower data, and the statistics
show the signiﬁcant diﬀerence.
atleastthestoredsamplesshouldbethawedlessthan3times.
Otherwise you will get the wrong data.
In conclusion, this CRAMP ELISA could become a
powerful tool for investigating the relationship between
human aging and telomere length shortening. The detail
mechanisms need much more researches. We still need to
prove the ELISA sensitivity and speciﬁcity through the way
of samples’ high quality control.
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